ArticleJournal of cancer research and clinical oncology2023

Emerging glyco-risk prediction model to forecast response to immune checkpoint inhibitors in colorectal cancer.

Peishan Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.